Dataset Information


Promoter hypermethylation in MLL-r leukemia: biology and therapeutic targeting

ABSTRACT: MLL-r infant acute lymphoblastic leukemia (ALL) has largely unclear oncogenesis. It has been shown unrelated to copy number change or mutations in the tyrosine kinome. We therefore, explored the possible role of genome wide CpG island hypermethylation in MLL-r infant ALL. We employed the HpaII-tiny fragment Enrichment by Ligation-mediated PCR (HELP) assay to examine MLL-r infant leukemia samples (n=5), other common childhood ALL (n=5) and normals (n=5). We then investigated biological correlation and the therapeutic potential of 5-aza-2’-deoxycytidine (decitabine). Analysis of the HELP assay showed both tight clustering of samples into their biological groups and that MLL-r infant leukemia was globally and comparatively hypermethylated. Further, a majority of genes chosen for analysis from the HELP assay were silenced or under-expressed. MLL-r cell lines showed dose and time-dependent cell kill when treated with decitabine and most down-regulated genes showed increase in expression. This was not seen in the MLL-wt cell line. For the re-expressed genes, methylation specific PCR confirmed preferential promoter methylation in MLL-r samples. Together, this suggests that methylation signatures are unique in pediatric ALL, that promoter hypermethylation may play a significant role in MLL-r infant leukemogenesis, that this can be reversed and demethylating agents may be a potential new therapeutic option in infant leukemia. Keywords: DNA methylation profiling Direct comparison of DNA methylation in leukemic blasts from 5 infants with MLL-r ALL with 5 children with other common types of ALL and 5 normal samples consisting of CD34+ selected cord blood cells (n=3) and CD19+ selected cord blood cells (n=2)


ORGANISM(S): Homo sapiens  

SUBMITTER: Maria E Figueroa   Patrick Brown  Ari Melnick  Eric S Schafer  Eric Stephen Schafer 

PROVIDER: E-GEOD-19671 | ArrayExpress | 2009-12-29



Dataset's files

Action DRS
E-GEOD-19671.README.txt Txt
E-GEOD-19671.idf.txt Idf Processed Raw Raw
Items per page:
1 - 5 of 7
altmetric image


Promoter hypermethylation in MLL-r infant acute lymphoblastic leukemia: biology and therapeutic targeting.

Schafer Eric E   Irizarry Rafael R   Negi Sandeep S   McIntyre Emily E   Small Donald D   Figueroa Maria E ME   Melnick Ari A   Brown Patrick P  

Blood 20100309 23

Cooperating leukemogenic events in MLL-rearranged (MLL-r) infant acute lymphoblastic leukemia (ALL) are largely unknown. We explored the role of promoter CpG island hypermethylation in the biology and therapeutic targeting of MLL-r infant ALL. The HELP (HpaII tiny fragment enrichment by ligation-mediated polymerase chain reaction [PCR]) assay was used to examine genome-wide methylation of a cohort of MLL-r infant leukemia samples (n = 5), other common childhood ALLs (n = 5), and normals (n = 5).  ...[more]

Similar Datasets

2008-04-01 | E-GEOD-10894 | ArrayExpress
2010-01-01 | S-EPMC2890186 | BioStudies
2014-02-07 | E-GEOD-52151 | ArrayExpress
2013-06-27 | E-GEOD-38295 | ArrayExpress
2013-06-27 | E-GEOD-44860 | ArrayExpress
2009-12-29 | GSE19671 | GEO
2012-12-05 | E-GEOD-42721 | ArrayExpress
2010-01-12 | E-GEOD-18700 | ArrayExpress
2010-05-07 | E-GEOD-14417 | ArrayExpress
2015-05-20 | E-GEOD-60233 | ArrayExpress